| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
a Address correspondence to this author at: Centers for Disease Control and Prevention, 4770 Buford Hwy., NE, MS F-18, Atlanta, GA 30341-3724. Fax 770-488-4609; e-mail cfp8{at}cdc.gov
Background: Information on interlaboratory variation and especially on methodological differences for plasma total homocysteine is lacking.
Methods: We studied 14 laboratories that used eight different method types: HPLC with electrochemical detection (HPLC-ED); HPLC with fluorescence detection (HPLC-FD) further subdivided by type of reducing/derivatizing agent; gas chromatography/mass spectrometry (GC/MS); enzyme immunoassay (EIA); and fluorescence polarization immunoassay (FPIA). Three of these laboratories used two methods. The laboratories participated in a 2-day analysis of 46 plasma samples, 4 additional plasma samples with added homocystine, and 3 plasma quality-control (QC) pools. Results were analyzed for imprecision, recovery, and methodological differences.
Results: The mean among-laboratory and among-run within-laboratory imprecision (CV) was 9.3% and 5.6% for plasma samples, 8.8% and 4.9% for samples with added homocystine, and 7.6% and 4.2% for the QC pools, respectively. Difference plots showed values systematically higher than GC/MS for HPLC-ED, HPLC-FD using sodium borohydride/monobromobimane (however, for only one laboratory), and EIA, and lower values for HPLC-FD using trialkylphosphine/4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole. The two HPLC-FD methods using tris(2-carboxyethyl) phosphine/ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate (SBD-F) or tributyl phosphine/SBD-F, and the FPIA method showed no detectable systematic difference from GC/MS.
Conclusions: Among-laboratory variations within one method can exceed among-method variations. Some of the methods tested could be used interchangeably, but there is an urgent need to improve analytical imprecision and to decrease differences among methods.© 1999 American Association for Clinical Chemistry
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  H.-K. Kuo, K.-C. Liao, S. G. Leveille, J. F. Bean, C.-J. Yen, J.-H. Chen, Y.-H. Yu, and T.-Y. Tai Relationship of Homocysteine Levels to Quadriceps Strength, Gait Speed, and Late-Life Disability in Older Adults J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 434 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Guallar, E. K. Silbergeld, A. Navas-Acien, S. Malhotra, B. C. Astor, A. R. Sharrett, and B. S. Schwartz Confounding of the Relation between Homocysteine and Peripheral Arterial Disease by Lead, Cadmium, and Renal Function Am. J. Epidemiol., April 15, 2006; 163(8): 700 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-K. Kuo, J. F. Bean, C.-J. Yen, and S. G. Leveille Linking C-Reactive Protein to Late-Life Disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2006; 61(4): 380 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Mignini, P. M. Latthe, J. Villar, M. D. Kilby, G. Carroli, and K. S. Khan Mapping the Theories of Preeclampsia: The Role of Homocysteine Obstet. Gynecol., February 1, 2005; 105(2): 411 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Huijgen, F. P.W. Tegelaers, C. H.H. Schoenmakers, C. J. Pronk-Admiraal, and S. Ekema Multicenter Analytical Evaluation of an Enzymatic Method for the Measurement of Plasma Homocysteine and Comparison with HPLC and Immunochemistry Clin. Chem., May 1, 2004; 50(5): 937 - 940. [Full Text] [PDF]
|
|
|
|
|
|
H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al. Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion Clin. Chem., January 1, 2004; 50(1): 3 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tan, X. Sun, L. Tang, N. Zhang, Q. Han, M. Xu, X. Tan, X. Tan, and R. M. Hoffman Automated Enzymatic Assay for Homocysteine Clin. Chem., June 1, 2003; 49(6): 1029 - 1030. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Fokkema, M. F. Gilissen, J. J. van Doormaal, M. Volmer, I. P. Kema, and F. A.J. Muskiet Fasting vs Nonfasting Plasma Homocysteine Concentrations for Diagnosis of Hyperhomocysteinemia Clin. Chem., May 1, 2003; 49(5): 818 - 821. [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Blanck, B. A. Bowman, G. R. Cooper, G. L. Myers, and D. T. Miller Laboratory Issues: Use of Nutritional Biomarkers J. Nutr., March 1, 2003; 133(3): 888S - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Q. Hanson, J. H. Eckfeldt, K. Schwichtenberg, O. Aras, and M. Y. Tsai Interlaboratory Variation of Plasma Total Homocysteine Measurements: Results of Three Successive Homocysteine Proficiency Testing Surveys Clin. Chem., September 1, 2002; 48(9): 1539 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Kelly, J. Rosand, J. P. Kistler, V. E. Shih, S. Silveira, A. Plomaritoglou, and K. L. Furie Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: Results of a meta-analysis Neurology, August 27, 2002; 59(4): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Krijt, M. Vackova, and V. Kozich Measurement of Homocysteine and Other Aminothiols in Plasma: Advantages of Using Tris(2-carboxyethyl)phosphine as Reductant Compared with Tri-n-butylphosphine Clin. Chem., October 1, 2001; 47(10): 1821 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhang, E. W. Gunter, and C. M. Pfeiffer Evaluation of the Drew Scientific DS30 Homocysteine Assay in Comparison with the Centers for Disease Control and Prevention Reference HPLC Method Clin. Chem., May 1, 2001; 47(5): 966 - 967. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Pfeiffer, S. P. Caudill, E. W. Gunter, B. A. Bowman, P. F. Jacques, J. Selhub, C. L. Johnson, D. T. Miller, and E. J. Sampson Analysis of Factors Influencing the Comparison of Homocysteine Values between the Third National Health and Nutrition Examination Survey (NHANES) and NHANES 1999+ J. Nutr., November 1, 2000; 130(11): 2850 - 2854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tan, L. Tang, X. Sun, N. Zhang, Q. Han, M. Xu, E. Baranov, X. Tan, X. Tan, B. Rashidi, et al. Total-Homocysteine Enzymatic Assay, Clin. Chem., October 1, 2000; 46(10): 1686 - 1688. [Full Text] [PDF]
|
|
|
|
|
|
E. Nexo, F. Engbaek, P. M. Ueland, C. Westby, P. O'Gorman, C. Johnston, B. F. Kase, A. B. Guttormsen, I. Alfheim, J. McPartlin, et al. Evaluation of Novel Assays in Clinical Chemistry: Quantification of Plasma Total Homocysteine Clin. Chem., August 1, 2000; 46(8): 1150 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Assessment of Laboratory Tests for Plasma Homocysteine--Selected Laboratories, July-September 1998 JAMA, December 8, 1999; 282(22): 2112 - 2113. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Pfeiffer, S. J. Smith, D. T. Miller, and E. W. Gunter Comparison of Serum and Plasma Methylmalonic Acid Measurements in 13 Laboratories: An International Study Clin. Chem., December 1, 1999; 45(12): 2236 - 2242. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
